End-of-day quote
Shenzhen S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
22.56
CNY
|
+0.45%
|
|
-5.69%
|
-33.37%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
4,860
|
4,139
|
2,758
|
-
|
Enterprise Value (EV)
1 |
4,860
|
4,139
|
2,758
|
2,758
|
P/E ratio
|
22.6
x
|
36.8
x
|
13.8
x
|
10.6
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.4
x
|
10.1
x
|
4.83
x
|
3.71
x
|
EV / Revenue
|
10.4
x
|
10.1
x
|
4.83
x
|
3.71
x
|
EV / EBITDA
|
23.4
x
|
25.7
x
|
12.5
x
|
9.33
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
2.8
x
|
2.29
x
|
1.38
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
122,246
|
122,246
|
122,246
|
-
|
Reference price
2 |
39.75
|
33.86
|
22.56
|
22.56
|
Announcement Date
|
10/04/23
|
18/04/24
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
465.5
|
410.5
|
571
|
743
|
EBITDA
1 |
-
|
207.6
|
161.2
|
220.6
|
295.7
|
EBIT
1 |
-
|
179.9
|
129.5
|
223.4
|
290.9
|
Operating Margin
|
-
|
38.64%
|
31.55%
|
39.12%
|
39.15%
|
Earnings before Tax (EBT)
1 |
-
|
183.6
|
130.2
|
222.3
|
289.8
|
Net income
1 |
130.7
|
161.9
|
112.6
|
200
|
260.8
|
Net margin
|
-
|
34.77%
|
27.42%
|
35.04%
|
35.1%
|
EPS
2 |
1.423
|
1.760
|
0.9200
|
1.640
|
2.130
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/03/22
|
10/04/23
|
18/04/24
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
---|
Net sales
1 |
33.09
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
|
-
|
Net margin
|
-
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
18/04/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
10.3%
|
6.37%
|
10.5%
|
12.4%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
14.20
|
14.80
|
16.30
|
18.10
|
Cash Flow per Share
2 |
-
|
1.140
|
0.7100
|
1.540
|
1.910
|
Capex
1 |
-
|
-
|
197
|
103
|
104
|
Capex / Sales
|
-
|
-
|
47.95%
|
17.98%
|
14%
|
Announcement Date
|
10/03/22
|
10/04/23
|
18/04/24
|
-
|
-
|
Last Close Price
22.56
CNY Average target price
45.82
CNY Spread / Average Target +103.10% Consensus |
1st Jan change
|
Capi.
|
---|
| -33.37% | 382M | | +10.10% | 27.85B | | -30.22% | 3.09B | | +35.19% | 2.66B | | -18.85% | 2.44B | | +6.85% | 2.24B | | +33.33% | 2.05B | | -4.71% | 2.02B | | +34.05% | 1.35B | | +3.33% | 1.33B |
Medical Supplies
|